LABORATORY MARKERS FOR PREDICTING AGGRAVATION AND POOR PROGNOSIS IN PATIENTS WITH COVID-19
Hematology, Transfusion and Cell Therapy
; 43:S48-S49, 2021.
Article
in English
| EMBASE | ID: covidwho-1859592
biochemical marker; CD19 antigen; CD3 antigen; CD4 antigen; CD8 antigen; endogenous compound; receptor type tyrosine protein phosphatase C; adult; bacterial pneumonia; blood cell count; blood sampling; CD4 lymphocyte count; CD8 lymphocyte count; clinical article; conference abstract; controlled study; coronavirus disease 2019; female; flow cytometry; follow up; gender; hospital discharge; human; human cell; leukocyte; lymphocyte; lymphocyte count; lymphocyte subpopulation; lymphocytopenia; male; neutrophil; neutrophil lymphocyte ratio; neutrophilia; outcome assessment; prognosis; receiver operating characteristic; software; T lymphocyte
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Prognostic study
Language:
English
Journal:
Hematology, Transfusion and Cell Therapy
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS